The price of Healthcare Realty Trust Inc (NYSE: HR) closed at $13.56 in the last session, down -1.45% from day before closing price of $13.76. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 2343398 shares were traded. HR stock price reached its highest trading level at $13.90 during the session, while it also had its lowest trading level at $13.49.
Ratios:
We take a closer look at HR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 201.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.34. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on February 20, 2024, Downgraded its rating to Neutral and sets its target price to $15 from $19 previously.
On February 20, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $19 to $15.
On January 30, 2024, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $18.Deutsche Bank initiated its Hold rating on January 30, 2024, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’23 when Hull Robert E sold 25,394 shares for $17.01 per share. The transaction valued at 431,952 led to the insider holds 169,257 shares of the business.
Wilson Julie F. sold 4,100 shares of HR for $70,930 on Dec 15 ’23. The EVP – Operations now owns 116,233 shares after completing the transaction at $17.30 per share. On Aug 16 ’23, another insider, SINGLETON JOHN KNOX, who serves as the Director of the company, bought 31,500 shares for $17.11 each. As a result, the insider paid 538,965 and bolstered with 50,582 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HR now has a Market Capitalization of 5.17B and an Enterprise Value of 10.44B. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.85 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 7.77 whereas that against EBITDA is 14.07.
Stock Price History:
Over the past 52 weeks, HR has reached a high of $20.32, while it has fallen to a 52-week low of $13.06. The 50-Day Moving Average of the stock is 15.83, while the 200-Day Moving Average is calculated to be 16.68.
Shares Statistics:
According to the various share statistics, HR traded on average about 3.16M shares per day over the past 3-months and 3.54M shares per day over the past 10 days. A total of 380.96M shares are outstanding, with a floating share count of 379.01M. Insiders hold about 0.57% of the company’s shares, while institutions hold 106.41% stake in the company. Shares short for HR as of Feb 15, 2024 were 9.59M with a Short Ratio of 3.04, compared to 9.43M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.52% and a Short% of Float of 4.22%.
Dividends & Splits
The forward annual dividend rate for HR is 1.24, which was 1.24 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 9.01%, it implies a Forward Annual Dividend Yield of 9.14%. The stock’s 5-year Average Dividend Yield is 4.59.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.14, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.43 and -$0.5 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is -$0.42, with 5 analysts recommending between -$0.37 and -$0.45.
Revenue Estimates
According to 3 analysts, the current quarter’s revenue is expected to be $326.73M. It ranges from a high estimate of $328.9M to a low estimate of $324.3M. As of the current estimate, Healthcare Realty Trust Inc’s year-ago sales were $329M, an estimated decrease of -0.70% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $328.43M, a decrease of -1.00% less than the figure of -$0.70% in the same quarter last year. There is a high estimate of $330M for the next quarter, whereas the lowest estimate is $327.1M.
A total of 5 analysts have provided revenue estimates for HR’s current fiscal year. The highest revenue estimate was $1.34B, while the lowest revenue estimate was $1.31B, resulting in an average revenue estimate of $1.33B. In the same quarter a year ago, actual revenue was $1.34B, down -1.30% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $1.37B in the next fiscal year. The high estimate is $1.37B and the low estimate is $1.36B. The average revenue growth estimate for next year is up 2.90% from the average revenue estimate for this year.
